Status:
RECRUITING
Non-Invasive Neuromodulation for Upper Extremity Function in Spinal Cord Injury: A Crossover Trial
Lead Sponsor:
University of Alberta
Collaborating Sponsors:
Praxis Spinal Cord Institute
Conditions:
Spinal Cord Injury Cervical
Eligibility:
All Genders
18-75 years
Phase:
PHASE2
PHASE3
Brief Summary
This study explores two promising therapies for restoring arm and hand function in people with chronic cervical spinal cord injury (SCI), a condition that affects independence and quality of life. It ...
Detailed Description
Project Aims The key objective of this pilot is to explore the feasibility of a comparative trial between two non-invasive neuromodulatory approaches for restoration of upper extremity function after...
Eligibility Criteria
Inclusion
- Cervical (C2-C8) level SCI
- \> 9 months post-injury
- Traumatic SCI
- AIS A-D
- Stable dose of anti-spasmodics
Exclusion
- individuals with injury to the nervous system other than to the spinal cord
- pregnant
Key Trial Info
Start Date :
May 7 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2030
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT06903416
Start Date
May 7 2025
End Date
March 31 2030
Last Update
May 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Glenrose Rehabilitation Hospital
Edmonton, Alberta, Canada, T5G0B7